Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.910
-0.010 (-0.52%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Treace Medical Concepts Revenue
In the year 2025, Treace Medical Concepts had annual revenue of $212.69M with 1.59% growth. Treace Medical Concepts had revenue of $62.52M in the quarter ending December 31, 2025, a decrease of -9.01%.
Revenue (ttm)
$212.69M
Revenue Growth
+1.59%
P/S Ratio
0.58
Revenue / Employee
$472,644
Employees
450
Market Cap
123.42M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 348.67M |
| Neuronetics | 149.16M |
| Quanterix | 138.90M |
| Owlet | 105.71M |
| AVITA Medical | 71.61M |
| Apyx Medical | 52.84M |
| SANUWAVE Health | 44.05M |
| Rapid Micro Biosystems | 33.59M |
TMCI News
- 4 days ago - Treace to Report First Quarter 2026 Financial Results on May 8, 2026 - GlobeNewsWire
- 21 days ago - Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System - GlobeNewsWire
- 2 months ago - Treace Medical Concepts Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference - GlobeNewsWire
- 2 months ago - Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026 - GlobeNewsWire
- 3 months ago - Treace Medical Concepts Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 3 months ago - Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue - GlobeNewsWire